학술논문
Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study
Document Type
Article
Author
Source
In Blood 22 February 2024 143(8):713-720
Subject
Language
ISSN
0006-4971